CA2633918A1 - Substituted imidazoline derivatives - Google Patents
Substituted imidazoline derivatives Download PDFInfo
- Publication number
- CA2633918A1 CA2633918A1 CA002633918A CA2633918A CA2633918A1 CA 2633918 A1 CA2633918 A1 CA 2633918A1 CA 002633918 A CA002633918 A CA 002633918A CA 2633918 A CA2633918 A CA 2633918A CA 2633918 A1 CA2633918 A1 CA 2633918A1
- Authority
- CA
- Canada
- Prior art keywords
- dihydro
- imidazole
- carboxylic acid
- methyl ester
- acid methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000002462 imidazolines Chemical class 0.000 title claims abstract description 48
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 title claims abstract description 35
- 239000003814 drug Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 67
- -1 4-Cl-benzyl Chemical group 0.000 claims description 48
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 38
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 35
- 150000001299 aldehydes Chemical class 0.000 claims description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 29
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 26
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 22
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 18
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 18
- 208000002193 Pain Diseases 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 15
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 13
- 238000003786 synthesis reaction Methods 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 11
- 150000007513 acids Chemical class 0.000 claims description 11
- 150000005840 aryl radicals Chemical group 0.000 claims description 11
- 125000001544 thienyl group Chemical group 0.000 claims description 10
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 9
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 8
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- 150000003254 radicals Chemical class 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 7
- 208000000094 Chronic Pain Diseases 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 6
- IWGVZQAPMJDBGE-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 IWGVZQAPMJDBGE-UHFFFAOYSA-N 0.000 claims description 6
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 206010012735 Diarrhoea Diseases 0.000 claims description 4
- 208000003251 Pruritus Diseases 0.000 claims description 4
- 206010046543 Urinary incontinence Diseases 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 150000004702 methyl esters Chemical class 0.000 claims description 4
- 208000004296 neuralgia Diseases 0.000 claims description 4
- 230000002981 neuropathic effect Effects 0.000 claims description 4
- 208000021722 neuropathic pain Diseases 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- MIHGGZOJCPTLTI-UHFFFAOYSA-N 2-[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]acetaldehyde Chemical compound C1CC(CC=O)CCC1C(N(C)C)CCC1=CC=CC=C1 MIHGGZOJCPTLTI-UHFFFAOYSA-N 0.000 claims description 3
- 208000019901 Anxiety disease Diseases 0.000 claims description 3
- DJAMXGJKOZCVJC-UHFFFAOYSA-N C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 DJAMXGJKOZCVJC-UHFFFAOYSA-N 0.000 claims description 3
- HXJFSFOOAWTVQN-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl HXJFSFOOAWTVQN-UHFFFAOYSA-N 0.000 claims description 3
- UYSWIRADPTZPLN-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCCC Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCCC UYSWIRADPTZPLN-UHFFFAOYSA-N 0.000 claims description 3
- GREDRVCBDLFPGT-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 GREDRVCBDLFPGT-UHFFFAOYSA-N 0.000 claims description 3
- MAUSLMGMYDVUQB-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl MAUSLMGMYDVUQB-UHFFFAOYSA-N 0.000 claims description 3
- OGOGQDWGOWDHPZ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC OGOGQDWGOWDHPZ-UHFFFAOYSA-N 0.000 claims description 3
- KBDOWHOIOUBRKJ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 Chemical compound COC(=O)C1(N=CN(C1C1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 KBDOWHOIOUBRKJ-UHFFFAOYSA-N 0.000 claims description 3
- WWGKSILMGXHCQJ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CSCC1=CC=CC=C1 WWGKSILMGXHCQJ-UHFFFAOYSA-N 0.000 claims description 3
- PLAHKKIIOPOVNT-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CCCC PLAHKKIIOPOVNT-UHFFFAOYSA-N 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 3
- 208000005298 acute pain Diseases 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000036506 anxiety Effects 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- OIICSYADHRIQJO-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1CC1=CC=CC=C1 OIICSYADHRIQJO-UHFFFAOYSA-N 0.000 claims description 3
- AJRAORCRKJFDRX-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-[(4-chlorophenyl)methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(C2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 AJRAORCRKJFDRX-UHFFFAOYSA-N 0.000 claims description 3
- UMVZSUJJCJKGKW-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1CC1=CC=CC=C1 UMVZSUJJCJKGKW-UHFFFAOYSA-N 0.000 claims description 3
- VLXDQVDEQYTOED-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 VLXDQVDEQYTOED-UHFFFAOYSA-N 0.000 claims description 3
- SAKCACZLKYADOK-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(C(=O)OC)(CC(C)C)N=CN1CC1=CC=CC=C1 SAKCACZLKYADOK-UHFFFAOYSA-N 0.000 claims description 3
- VTWRORWDADHKFE-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 VTWRORWDADHKFE-UHFFFAOYSA-N 0.000 claims description 3
- SWKNNMIWXDGVQV-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(C(=O)OC)(CSC)N=CN1CC1=CC=CC=C1 SWKNNMIWXDGVQV-UHFFFAOYSA-N 0.000 claims description 3
- LJRRTUZRLNYNNV-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 LJRRTUZRLNYNNV-UHFFFAOYSA-N 0.000 claims description 3
- XCBPYRVYYVUORS-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1CC1=CC=CC=C1 XCBPYRVYYVUORS-UHFFFAOYSA-N 0.000 claims description 3
- KUOAGWCKWOCREZ-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 KUOAGWCKWOCREZ-UHFFFAOYSA-N 0.000 claims description 3
- KUOAMXRUFSIQIQ-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(C(=O)OC)(C)N=CN1CC1=CC=CC=C1 KUOAMXRUFSIQIQ-UHFFFAOYSA-N 0.000 claims description 3
- SVTONLHXVSCFEC-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1CC1=CC=CC=C1 SVTONLHXVSCFEC-UHFFFAOYSA-N 0.000 claims description 3
- UFTNGKKYXRIDBG-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(C(=O)OC)(C)N=CN1CC1=CC=CC=C1 UFTNGKKYXRIDBG-UHFFFAOYSA-N 0.000 claims description 3
- WARRDGNMHZRTQP-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 WARRDGNMHZRTQP-UHFFFAOYSA-N 0.000 claims description 3
- WRSJNNDEPMLFEJ-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(C2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 WRSJNNDEPMLFEJ-UHFFFAOYSA-N 0.000 claims description 3
- SOPYTKCRBDRUQB-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(C2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 SOPYTKCRBDRUQB-UHFFFAOYSA-N 0.000 claims description 3
- UGSDRXNLIQGMCN-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 UGSDRXNLIQGMCN-UHFFFAOYSA-N 0.000 claims description 3
- MPNCLXBLPSQJMJ-UHFFFAOYSA-N methyl 3-benzyl-5-(benzylsulfanylmethyl)-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(CC2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 MPNCLXBLPSQJMJ-UHFFFAOYSA-N 0.000 claims description 3
- QTPBGYPVWOIAFP-UHFFFAOYSA-N methyl 3-benzyl-5-[(4-chlorophenyl)methyl]-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(CC=2C=CC=CC=2)C(C2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 QTPBGYPVWOIAFP-UHFFFAOYSA-N 0.000 claims description 3
- VNVIXYWKQXGNFQ-UHFFFAOYSA-N methyl 3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 VNVIXYWKQXGNFQ-UHFFFAOYSA-N 0.000 claims description 3
- WLDLICZFVWOUTE-UHFFFAOYSA-N methyl 3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-[(4-chlorophenyl)methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(CCCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 WLDLICZFVWOUTE-UHFFFAOYSA-N 0.000 claims description 3
- REZARQLAHUEAOG-UHFFFAOYSA-N methyl 3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 REZARQLAHUEAOG-UHFFFAOYSA-N 0.000 claims description 3
- JNASVVSNXIRSGH-UHFFFAOYSA-N methyl 3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 JNASVVSNXIRSGH-UHFFFAOYSA-N 0.000 claims description 3
- AJADKPRMVOXCKO-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 AJADKPRMVOXCKO-UHFFFAOYSA-N 0.000 claims description 3
- UKRNLSDIOFQGQP-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 UKRNLSDIOFQGQP-UHFFFAOYSA-N 0.000 claims description 3
- VTCOBRHXWIBSFZ-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 VTCOBRHXWIBSFZ-UHFFFAOYSA-N 0.000 claims description 3
- HHCOWMRXOBBYEI-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 HHCOWMRXOBBYEI-UHFFFAOYSA-N 0.000 claims description 3
- SCJYTXWDTANZHP-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 SCJYTXWDTANZHP-UHFFFAOYSA-N 0.000 claims description 3
- QPYFAEQAZRVDIK-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 QPYFAEQAZRVDIK-UHFFFAOYSA-N 0.000 claims description 3
- NIWDBFQCBIRAAY-UHFFFAOYSA-N methyl 3-butyl-5-[(4-chlorophenyl)methyl]-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1N(CCCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 NIWDBFQCBIRAAY-UHFFFAOYSA-N 0.000 claims description 3
- QFEYWLJWQHGTAH-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CC(C)C)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 QFEYWLJWQHGTAH-UHFFFAOYSA-N 0.000 claims description 3
- XKUMVTDDJYRYRX-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 XKUMVTDDJYRYRX-UHFFFAOYSA-N 0.000 claims description 3
- AYGNULSLFTYDIP-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 AYGNULSLFTYDIP-UHFFFAOYSA-N 0.000 claims description 3
- WNWWSUOCXNXRAQ-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 WNWWSUOCXNXRAQ-UHFFFAOYSA-N 0.000 claims description 3
- XGSYPCLYMGCBFG-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CSCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 XGSYPCLYMGCBFG-UHFFFAOYSA-N 0.000 claims description 3
- YNBNWAIGBFERQF-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 YNBNWAIGBFERQF-UHFFFAOYSA-N 0.000 claims description 3
- IBSXYVMWVYBDAS-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 IBSXYVMWVYBDAS-UHFFFAOYSA-N 0.000 claims description 3
- RTXHASOGARYSJN-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CSCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 RTXHASOGARYSJN-UHFFFAOYSA-N 0.000 claims description 3
- SOMPOOCLHYJBGV-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 SOMPOOCLHYJBGV-UHFFFAOYSA-N 0.000 claims description 3
- ZVRLAGYLHFCASN-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 ZVRLAGYLHFCASN-UHFFFAOYSA-N 0.000 claims description 3
- FOWMRXMAENPXIX-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CC(C)C)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 FOWMRXMAENPXIX-UHFFFAOYSA-N 0.000 claims description 3
- UQPUMJIREWXFSH-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 UQPUMJIREWXFSH-UHFFFAOYSA-N 0.000 claims description 3
- GCDPODRUDPUGEY-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1C(C)C1=CC=CC=C1 GCDPODRUDPUGEY-UHFFFAOYSA-N 0.000 claims description 3
- CMRAJPYCLCBWRR-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 CMRAJPYCLCBWRR-UHFFFAOYSA-N 0.000 claims description 3
- HLYFOJRRGFMHKA-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 HLYFOJRRGFMHKA-UHFFFAOYSA-N 0.000 claims description 3
- VCQIDKQWKIGUPE-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 VCQIDKQWKIGUPE-UHFFFAOYSA-N 0.000 claims description 3
- LXKMRYDOALSBQK-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 LXKMRYDOALSBQK-UHFFFAOYSA-N 0.000 claims description 3
- UOCLNASTGKMBGT-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 UOCLNASTGKMBGT-UHFFFAOYSA-N 0.000 claims description 3
- SZRFJRYDBNOOBN-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 SZRFJRYDBNOOBN-UHFFFAOYSA-N 0.000 claims description 3
- VBERTXPENGLIEG-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(C(=O)OC)(CC(C)C)N=CN1C(C)C1=CC=CC=C1 VBERTXPENGLIEG-UHFFFAOYSA-N 0.000 claims description 3
- BDTVIRQRXDRHGF-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 BDTVIRQRXDRHGF-UHFFFAOYSA-N 0.000 claims description 3
- NFSKAEQBOYBCAK-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 NFSKAEQBOYBCAK-UHFFFAOYSA-N 0.000 claims description 3
- ZWPYOPROTVGVBN-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 ZWPYOPROTVGVBN-UHFFFAOYSA-N 0.000 claims description 3
- ISCXJARTILLMPP-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 ISCXJARTILLMPP-UHFFFAOYSA-N 0.000 claims description 3
- DUDXSPVEEAMNEB-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-[(4-chlorophenyl)methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 DUDXSPVEEAMNEB-UHFFFAOYSA-N 0.000 claims description 3
- XLDWAYVSNDCSBW-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-3,5-dipropyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 XLDWAYVSNDCSBW-UHFFFAOYSA-N 0.000 claims description 3
- ZHSVWBIMKQNTHM-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(C(=O)OC)(CCSC)N=CN1C(C)C1=CC=CC=C1 ZHSVWBIMKQNTHM-UHFFFAOYSA-N 0.000 claims description 3
- BDNBBAXMEOAQJP-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 BDNBBAXMEOAQJP-UHFFFAOYSA-N 0.000 claims description 3
- PLBONUWJQZOADP-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 PLBONUWJQZOADP-UHFFFAOYSA-N 0.000 claims description 3
- PYBDTQRCOJCMFB-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 PYBDTQRCOJCMFB-UHFFFAOYSA-N 0.000 claims description 3
- JNWXAISXZFYSPY-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-methyl-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(CCC1=CC=CC=C1)N(C)C)C(C)C1=CC=CC=C1)C JNWXAISXZFYSPY-UHFFFAOYSA-N 0.000 claims description 3
- WLHLSMGXPCYYPU-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-3,5-dipropyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 WLHLSMGXPCYYPU-UHFFFAOYSA-N 0.000 claims description 3
- XYSWUMKLRGUTCG-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 XYSWUMKLRGUTCG-UHFFFAOYSA-N 0.000 claims description 3
- DUEMRIDOKVCHAO-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-3,5-dipropyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 DUEMRIDOKVCHAO-UHFFFAOYSA-N 0.000 claims description 3
- NLHQNESOJZRKOU-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 NLHQNESOJZRKOU-UHFFFAOYSA-N 0.000 claims description 3
- HYYPVXOREJPWCK-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 HYYPVXOREJPWCK-UHFFFAOYSA-N 0.000 claims description 3
- LNSOHNWWBRUVKN-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 LNSOHNWWBRUVKN-UHFFFAOYSA-N 0.000 claims description 3
- BKSFAMIJYPYVFD-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 BKSFAMIJYPYVFD-UHFFFAOYSA-N 0.000 claims description 3
- VNSLSUKERKFYLK-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(C2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 VNSLSUKERKFYLK-UHFFFAOYSA-N 0.000 claims description 3
- BMSRTONGNNEHSI-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(C2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 BMSRTONGNNEHSI-UHFFFAOYSA-N 0.000 claims description 3
- CXICYXNSHPYDBW-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 CXICYXNSHPYDBW-UHFFFAOYSA-N 0.000 claims description 3
- CXGSCIVCHWYZCK-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 CXGSCIVCHWYZCK-UHFFFAOYSA-N 0.000 claims description 3
- IQFJDUNSHNDMPA-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2C=CC(Cl)=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 IQFJDUNSHNDMPA-UHFFFAOYSA-N 0.000 claims description 3
- FSEDYUOXARTCQS-UHFFFAOYSA-N methyl 5-[(4-chlorophenyl)methyl]-3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(C2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 FSEDYUOXARTCQS-UHFFFAOYSA-N 0.000 claims description 3
- SCVGIOKQZFKPOH-UHFFFAOYSA-N methyl 5-[(4-chlorophenyl)methyl]-3-cyclohexyl-4-[[4-[dimethylamino(thiophen-2-yl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2SC=CC=2)C1(C(=O)OC)CC1=CC=C(Cl)C=C1 SCVGIOKQZFKPOH-UHFFFAOYSA-N 0.000 claims description 3
- FVASXSXRJLPEAX-UHFFFAOYSA-N methyl 5-butan-2-yl-3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(C(C)CC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 FVASXSXRJLPEAX-UHFFFAOYSA-N 0.000 claims description 3
- YQSXCVHDRMLYEZ-UHFFFAOYSA-N methyl 5-butan-2-yl-3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(C(C)CC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 YQSXCVHDRMLYEZ-UHFFFAOYSA-N 0.000 claims description 3
- WLJZCQLTOQQPED-UHFFFAOYSA-N methyl 5-butan-2-yl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(C(C)CC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 WLJZCQLTOQQPED-UHFFFAOYSA-N 0.000 claims description 3
- DERPEMCHDGVREK-UHFFFAOYSA-N methyl 5-butyl-3-cyclohexyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 DERPEMCHDGVREK-UHFFFAOYSA-N 0.000 claims description 3
- YQKNRFFVZLGAAC-UHFFFAOYSA-N methyl 5-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(CCC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 YQKNRFFVZLGAAC-UHFFFAOYSA-N 0.000 claims description 3
- VGRKVGNCRJBHDN-UHFFFAOYSA-N methyl 5-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(CCC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 VGRKVGNCRJBHDN-UHFFFAOYSA-N 0.000 claims description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- AEDHDWSEIWJPNN-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C AEDHDWSEIWJPNN-UHFFFAOYSA-N 0.000 claims description 2
- JSVFNTXHMJSQAA-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C(C)CC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)C(C)CC JSVFNTXHMJSQAA-UHFFFAOYSA-N 0.000 claims description 2
- VWNGOHLPRNXWSI-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC(=CC=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC VWNGOHLPRNXWSI-UHFFFAOYSA-N 0.000 claims description 2
- ZUQIBNCWRPPZGA-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)C Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)C ZUQIBNCWRPPZGA-UHFFFAOYSA-N 0.000 claims description 2
- WGOOYOGUPPPBFZ-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(C1=CC=C(C=C1)F)N(C)C)C(C)C1=CC=CC=C1)CCC WGOOYOGUPPPBFZ-UHFFFAOYSA-N 0.000 claims description 2
- RHGRPTRWSNOMSX-UHFFFAOYSA-N COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)C(C)C1=CC=CC=C1)CC1=CC=C(C=C1)Cl RHGRPTRWSNOMSX-UHFFFAOYSA-N 0.000 claims description 2
- RVLDMZMSKNSEKL-UHFFFAOYSA-N methyl 1-benzyl-5-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-4-(3-methoxy-3-oxopropyl)-4,5-dihydroimidazole-2-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC(=O)OC)N=C(C(=O)OC)N1CC1=CC=CC=C1 RVLDMZMSKNSEKL-UHFFFAOYSA-N 0.000 claims description 2
- CCXOXPMGQFLQHJ-UHFFFAOYSA-N methyl 3,5-dibutyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCCC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 CCXOXPMGQFLQHJ-UHFFFAOYSA-N 0.000 claims description 2
- HZSDETPZXMKBHT-UHFFFAOYSA-N methyl 3,5-dibutyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 HZSDETPZXMKBHT-UHFFFAOYSA-N 0.000 claims description 2
- PBJSGMLNNZKQOM-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(C(=O)OC)(CCSC)N=CN1CC1=CC=CC=C1 PBJSGMLNNZKQOM-UHFFFAOYSA-N 0.000 claims description 2
- YLUHHXLCDOZSMK-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(C(=O)OC)(C)N=CN1CC1=CC=CC=C1 YLUHHXLCDOZSMK-UHFFFAOYSA-N 0.000 claims description 2
- SGYIPPLJSBCLBH-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(CCC=2C=CC=CC=2)N(C)C)CCC1CC1C(CCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 SGYIPPLJSBCLBH-UHFFFAOYSA-N 0.000 claims description 2
- LVNCRMSUSOJHHD-UHFFFAOYSA-N methyl 3-benzyl-5-butyl-4-[[4-[(2-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C(=CC=CC=2)Cl)CCC1CC1C(CCCC)(C(=O)OC)N=CN1CC1=CC=CC=C1 LVNCRMSUSOJHHD-UHFFFAOYSA-N 0.000 claims description 2
- MZIFSGBZMCSNOA-UHFFFAOYSA-N methyl 3-butyl-4-[4-[(2-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C(=CC=CC=2)Cl)CC1 MZIFSGBZMCSNOA-UHFFFAOYSA-N 0.000 claims description 2
- ALOWJZPJDRSSTI-UHFFFAOYSA-N methyl 3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 ALOWJZPJDRSSTI-UHFFFAOYSA-N 0.000 claims description 2
- QPNIIOCKINOLFT-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(2-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C(=CC=CC=2)Cl)CC1 QPNIIOCKINOLFT-UHFFFAOYSA-N 0.000 claims description 2
- NKQQWQRRZRRFRX-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 NKQQWQRRZRRFRX-UHFFFAOYSA-N 0.000 claims description 2
- PBAAOJZERQIIBB-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 PBAAOJZERQIIBB-UHFFFAOYSA-N 0.000 claims description 2
- AJUOYZJWHWRCCU-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-methyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 AJUOYZJWHWRCCU-UHFFFAOYSA-N 0.000 claims description 2
- LPGVYFOFYXQYHY-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 LPGVYFOFYXQYHY-UHFFFAOYSA-N 0.000 claims description 2
- JKALKYGKBNRTHA-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 JKALKYGKBNRTHA-UHFFFAOYSA-N 0.000 claims description 2
- GNYPIBKKZXSZKO-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CSCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 GNYPIBKKZXSZKO-UHFFFAOYSA-N 0.000 claims description 2
- SNTVZUISJPOPCK-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 SNTVZUISJPOPCK-UHFFFAOYSA-N 0.000 claims description 2
- NUDGQZDSDCRMDJ-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)CCC1=CC=CC=C1 NUDGQZDSDCRMDJ-UHFFFAOYSA-N 0.000 claims description 2
- NGCDMEKTROWHHE-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 NGCDMEKTROWHHE-UHFFFAOYSA-N 0.000 claims description 2
- OUYNSHAMKRABSI-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 OUYNSHAMKRABSI-UHFFFAOYSA-N 0.000 claims description 2
- VHKBTODLZLQWCR-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)CCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 VHKBTODLZLQWCR-UHFFFAOYSA-N 0.000 claims description 2
- IAZCLGMPQUOEOY-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CSC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 IAZCLGMPQUOEOY-UHFFFAOYSA-N 0.000 claims description 2
- VBWXCKMTEHQIPD-UHFFFAOYSA-N methyl 4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-[(4-chlorophenyl)methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(CCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 VBWXCKMTEHQIPD-UHFFFAOYSA-N 0.000 claims description 2
- VMWKTXSJEUCPKU-UHFFFAOYSA-N methyl 4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(2-methylpropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(C(=O)OC)(CC(C)C)N=CN1C(C)C1=CC=CC=C1 VMWKTXSJEUCPKU-UHFFFAOYSA-N 0.000 claims description 2
- ANVCXFPGVBXCOW-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound COC(=O)C1(CC(C)C)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 ANVCXFPGVBXCOW-UHFFFAOYSA-N 0.000 claims description 2
- JVQNSVNIQSDZQL-UHFFFAOYSA-N methyl 4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-3-(1-phenylethyl)-5-propyl-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1CCC(CC1)C(CCC1=CC=CC=C1)N(C)C)C(C)C1=CC=CC=C1)CCC JVQNSVNIQSDZQL-UHFFFAOYSA-N 0.000 claims description 2
- OXHFCRDSQJVWCH-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1C(C)C1=CC=CC=C1 OXHFCRDSQJVWCH-UHFFFAOYSA-N 0.000 claims description 2
- IWGGCJZBMXBIDZ-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 IWGGCJZBMXBIDZ-UHFFFAOYSA-N 0.000 claims description 2
- SQUOVQSUDQKHKP-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 SQUOVQSUDQKHKP-UHFFFAOYSA-N 0.000 claims description 2
- ZCGSVAGZEPPMSS-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 ZCGSVAGZEPPMSS-UHFFFAOYSA-N 0.000 claims description 2
- KYOZQSKUJRFGOU-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(C(=O)OC)(CCSC)N=CN1C(C)C1=CC=CC=C1 KYOZQSKUJRFGOU-UHFFFAOYSA-N 0.000 claims description 2
- ASUOJGUWRMGALT-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-(1-phenylethyl)-4H-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1C(C)C1=CC=CC=C1 ASUOJGUWRMGALT-UHFFFAOYSA-N 0.000 claims description 2
- GRSHKVALSFDMQZ-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CCC(=O)OC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 GRSHKVALSFDMQZ-UHFFFAOYSA-N 0.000 claims description 2
- NWPOHFOHYBJQKQ-UHFFFAOYSA-N methyl 4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(methylsulfanylmethyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 NWPOHFOHYBJQKQ-UHFFFAOYSA-N 0.000 claims description 2
- FFOOAAURSHVRMP-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 FFOOAAURSHVRMP-UHFFFAOYSA-N 0.000 claims description 2
- AVXBEDJIZLNNCL-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-butyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1N(CCCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 AVXBEDJIZLNNCL-UHFFFAOYSA-N 0.000 claims description 2
- PYSFUFAZWFPFAX-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-cyclohexyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(CCC=2C=CC=CC=2)N(C)C)C1(C(=O)OC)CSCC1=CC=CC=C1 PYSFUFAZWFPFAX-UHFFFAOYSA-N 0.000 claims description 2
- IWKWOZDLMDYKQR-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound N1=CN(C2CCCCC2)C(CC2CCC(CC2)C(N(C)C)C=2C=C(F)C=CC=2)C1(C(=O)OC)CSCC1=CC=CC=C1 IWKWOZDLMDYKQR-UHFFFAOYSA-N 0.000 claims description 2
- VGECIDUREMTGJU-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1CC1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 VGECIDUREMTGJU-UHFFFAOYSA-N 0.000 claims description 2
- YZRLOXNTLZUMIM-UHFFFAOYSA-N methyl 5-(benzylsulfanylmethyl)-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1N(CCC)C=NC1(C(=O)OC)CSCC1=CC=CC=C1 YZRLOXNTLZUMIM-UHFFFAOYSA-N 0.000 claims description 2
- MOVJZAOFEKCKLI-UHFFFAOYSA-N methyl 5-[(4-chlorophenyl)methyl]-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-3-propyl-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1N(CCC)C=NC1(C(=O)OC)CC1=CC=C(Cl)C=C1 MOVJZAOFEKCKLI-UHFFFAOYSA-N 0.000 claims description 2
- UOBANTQSQBAULK-UHFFFAOYSA-N methyl 5-butan-2-yl-3-cyclohexyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCC(C)C1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=CC(F)=C1 UOBANTQSQBAULK-UHFFFAOYSA-N 0.000 claims description 2
- PMIRAVXKFWDXKT-UHFFFAOYSA-N methyl 5-butan-2-yl-3-cyclohexyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-4h-imidazole-5-carboxylate Chemical compound CCC(C)C1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(F)C=C1 PMIRAVXKFWDXKT-UHFFFAOYSA-N 0.000 claims description 2
- IOZOWVJZVPDWQS-UHFFFAOYSA-N methyl 5-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 IOZOWVJZVPDWQS-UHFFFAOYSA-N 0.000 claims description 2
- YTYAMJXQLTYBTK-UHFFFAOYSA-N 4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexane-1-carbaldehyde 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexane-1-carbaldehyde 4-[1-(dimethylamino)-3-phenylpropyl]cyclohexane-1-carbaldehyde Chemical compound CN(C)C(C1CCC(CC1)C=O)C1=CC(=CC=C1)F.CN(C(CCC1=CC=CC=C1)C1CCC(CC1)C=O)C.CN(C)C(C1CCC(CC1)C=O)C1=CC=C(C=C1)F YTYAMJXQLTYBTK-UHFFFAOYSA-N 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- MXZJLJCDQXVXEA-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 MXZJLJCDQXVXEA-UHFFFAOYSA-N 0.000 claims 1
- SBTIJPLBBCHHRC-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-propyl-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCC)(C(=O)OC)C1CC1CCC(C(CCC=2C=CC=CC=2)N(C)C)CC1 SBTIJPLBBCHHRC-UHFFFAOYSA-N 0.000 claims 1
- RDKJWOIQLZCMIU-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=C(F)C=CC=2)CC1 RDKJWOIQLZCMIU-UHFFFAOYSA-N 0.000 claims 1
- LLFKSPSUUKWVTI-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CCSC)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(F)=CC=2)CC1 LLFKSPSUUKWVTI-UHFFFAOYSA-N 0.000 claims 1
- LXZAPXFBSGEKMJ-UHFFFAOYSA-N methyl 5-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4-[(4-chlorophenyl)methyl]-1-cyclohexyl-4,5-dihydroimidazole-2-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(Cl)=CC=2)CCC1C1N(C2CCCCC2)C(C(=O)OC)=NC1CC1=CC=C(Cl)C=C1 LXZAPXFBSGEKMJ-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 96
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 88
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 84
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 73
- 239000000243 solution Substances 0.000 description 59
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 40
- 238000001816 cooling Methods 0.000 description 33
- 238000001704 evaporation Methods 0.000 description 32
- 230000008020 evaporation Effects 0.000 description 32
- 101150041968 CDC13 gene Proteins 0.000 description 28
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 28
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 21
- 229910052786 argon Inorganic materials 0.000 description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 239000008346 aqueous phase Substances 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 17
- 229910052938 sodium sulfate Inorganic materials 0.000 description 17
- 235000011152 sodium sulphate Nutrition 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- 125000001207 fluorophenyl group Chemical group 0.000 description 14
- SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 14
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 14
- 239000007832 Na2SO4 Substances 0.000 description 13
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 12
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000003818 flash chromatography Methods 0.000 description 11
- 150000002576 ketones Chemical class 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 125000005219 aminonitrile group Chemical group 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 238000010626 work up procedure Methods 0.000 description 6
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- HFBULKBCEFQYCJ-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]decane-8-carbaldehyde Chemical compound C1CC(C=O)CCC21OCCO2 HFBULKBCEFQYCJ-UHFFFAOYSA-N 0.000 description 4
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 239000005909 Kieselgur Substances 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000002541 furyl group Chemical group 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 229940127240 opiate Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- OTILTWNSTXKYQN-UHFFFAOYSA-N 4-[(dimethylamino)methyl]cyclohexane-1-carbaldehyde Chemical class CN(C)CC1CCC(C=O)CC1 OTILTWNSTXKYQN-UHFFFAOYSA-N 0.000 description 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000007818 Grignard reagent Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 125000000068 chlorophenyl group Chemical group 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- UXXWGBLTOSRBAY-UHFFFAOYSA-N ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate Chemical compound C1CC(C(=O)OCC)CCC21OCCO2 UXXWGBLTOSRBAY-UHFFFAOYSA-N 0.000 description 3
- 150000004795 grignard reagents Chemical class 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LFFZWEFAJJDMKZ-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethylmethanamine Chemical compound C1CC(CN(C)C)CCC21OCCO2 LFFZWEFAJJDMKZ-UHFFFAOYSA-N 0.000 description 2
- UVBHJMKYLQOHTO-UHFFFAOYSA-N 2-(dimethylamino)-2-(1,4-dioxaspiro[4.5]decan-8-yl)acetonitrile Chemical compound C1CC(C(C#N)N(C)C)CCC21OCCO2 UVBHJMKYLQOHTO-UHFFFAOYSA-N 0.000 description 2
- OMYSWSQWLSIWPW-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=C(Cl)C=CC=1C(N(C)C)C1CCC(CC=O)CC1 OMYSWSQWLSIWPW-UHFFFAOYSA-N 0.000 description 2
- SYMHWMKGOMWVFD-UHFFFAOYSA-N 2-[4-[dimethylamino(thiophen-2-yl)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=CSC=1C(N(C)C)C1CCC(CC=O)CC1 SYMHWMKGOMWVFD-UHFFFAOYSA-N 0.000 description 2
- BEFVDKBDNSOQFU-UHFFFAOYSA-N 2-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C1CCC(CC=O)CC1 BEFVDKBDNSOQFU-UHFFFAOYSA-N 0.000 description 2
- UJUIUNYYEYSDSS-UHFFFAOYSA-N 2-[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]acetaldehyde Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(CC=O)CC1 UJUIUNYYEYSDSS-UHFFFAOYSA-N 0.000 description 2
- HWLIOUQUSWVEAB-UHFFFAOYSA-N 4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=C(Cl)C=CC=1C(N(C)C)C1CCC(C=O)CC1 HWLIOUQUSWVEAB-UHFFFAOYSA-N 0.000 description 2
- CXDCQPPTWNFDAP-UHFFFAOYSA-N 4-[(dimethylamino)methyl]cyclohexan-1-one Chemical class CN(C)CC1CCC(=O)CC1 CXDCQPPTWNFDAP-UHFFFAOYSA-N 0.000 description 2
- SZZQUNGEKHJLSO-UHFFFAOYSA-N 4-[1-(dimethylamino)-3-phenylpropyl]cyclohexane-1-carbaldehyde Chemical compound C1CC(C=O)CCC1C(N(C)C)CCC1=CC=CC=C1 SZZQUNGEKHJLSO-UHFFFAOYSA-N 0.000 description 2
- TYXPQTLYRLSITM-UHFFFAOYSA-N 4-[dimethylamino(thiophen-2-yl)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=CSC=1C(N(C)C)C1CCC(C=O)CC1 TYXPQTLYRLSITM-UHFFFAOYSA-N 0.000 description 2
- QXNODLYWYULBDT-UHFFFAOYSA-N 4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C1CCC(C=O)CC1 QXNODLYWYULBDT-UHFFFAOYSA-N 0.000 description 2
- YTPAMINNYYCHGG-UHFFFAOYSA-N 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(C=O)CC1 YTPAMINNYYCHGG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- 229910004809 Na2 SO4 Inorganic materials 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZXYAWONOWHSQRU-UHFFFAOYSA-N ethyl 4-oxocyclohexanecarboxylate Chemical compound CCOC(=O)C1CCC(=O)CC1 ZXYAWONOWHSQRU-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 150000002527 isonitriles Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229960004127 naloxone Drugs 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- XZZNXMLSUXWNPQ-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-1-(3-fluorophenyl)-n,n-dimethylmethanamine Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C(CC1)CCC21OCCO2 XZZNXMLSUXWNPQ-UHFFFAOYSA-N 0.000 description 1
- TVLNOHUXNVXJGB-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethyl-1-thiophen-2-ylmethanamine Chemical compound C=1C=CSC=1C(N(C)C)C(CC1)CCC21OCCO2 TVLNOHUXNVXJGB-UHFFFAOYSA-N 0.000 description 1
- SGAKOIAUKSQAPH-UHFFFAOYSA-N 1-(1,4-dioxaspiro[4.5]decan-8-yl)-n,n-dimethyl-3-phenylpropan-1-amine Chemical compound C1CC2(OCCO2)CCC1C(N(C)C)CCC1=CC=CC=C1 SGAKOIAUKSQAPH-UHFFFAOYSA-N 0.000 description 1
- FFFIRKXTFQCCKJ-UHFFFAOYSA-N 2,4,6-trimethylbenzoic acid Chemical compound CC1=CC(C)=C(C(O)=O)C(C)=C1 FFFIRKXTFQCCKJ-UHFFFAOYSA-N 0.000 description 1
- GSMUVUIZLQIWSJ-UHFFFAOYSA-N 2-[4-[(dimethylamino)methyl]cyclohexyl]acetaldehyde Chemical class CN(C)CC1CCC(CC=O)CC1 GSMUVUIZLQIWSJ-UHFFFAOYSA-N 0.000 description 1
- VIKBNMWOLLIQPG-UHFFFAOYSA-N 2-methyldecanedioic acid Chemical compound OC(=O)C(C)CCCCCCCC(O)=O VIKBNMWOLLIQPG-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- CPJYYEMAVHISQF-UHFFFAOYSA-N 3,5-dibutyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-4H-imidazole-5-carboxylic acid Chemical compound C(CCC)N1C=NC(C1CC1CCC(CC1)C(N(C)C)C1=CC=C(C=C1)Cl)(C(=O)O)CCCC CPJYYEMAVHISQF-UHFFFAOYSA-N 0.000 description 1
- AJHPGXZOIAYYDW-UHFFFAOYSA-N 3-(2-cyanophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CC1=CC=CC=C1C#N AJHPGXZOIAYYDW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SXJDBONDCAPKQZ-UHFFFAOYSA-N 4-[1-(dimethylamino)-3-phenylpropyl]cyclohexan-1-one Chemical compound C1CC(=O)CCC1C(N(C)C)CCC1=CC=CC=C1 SXJDBONDCAPKQZ-UHFFFAOYSA-N 0.000 description 1
- HOYBGBLFHZPEGW-UHFFFAOYSA-N 4-[dimethylamino(thiophen-2-yl)methyl]cyclohexan-1-one Chemical compound C=1C=CSC=1C(N(C)C)C1CCC(=O)CC1 HOYBGBLFHZPEGW-UHFFFAOYSA-N 0.000 description 1
- JPVZNSBFRLDNEK-UHFFFAOYSA-N 4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexan-1-one Chemical compound C=1C=CC(F)=CC=1C(N(C)C)C1CCC(=O)CC1 JPVZNSBFRLDNEK-UHFFFAOYSA-N 0.000 description 1
- KLFLJXZRAXPMOU-UHFFFAOYSA-N 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexan-1-one Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(=O)CC1 KLFLJXZRAXPMOU-UHFFFAOYSA-N 0.000 description 1
- TVVCKGWHEFYCCM-UHFFFAOYSA-N 4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexane-1-carbaldehyde;4-[1-(dimethylamino)-3-phenylpropyl]cyclohexane-1-carbaldehyde Chemical compound C=1C=C(F)C=CC=1C(N(C)C)C1CCC(C=O)CC1.C1CC(C=O)CCC1C(N(C)C)CCC1=CC=CC=C1 TVVCKGWHEFYCCM-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- OWLXUYGCLDGHJJ-UHFFFAOYSA-N 4-oxocyclohexanecarboxylic acid Chemical class OC(=O)C1CCC(=O)CC1 OWLXUYGCLDGHJJ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical class CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 0 CC(CC(CC1)CCC1C(*)N(*)*)C1N(*)C=NC1(*)C(O*)=O Chemical compound CC(CC(CC1)CCC1C(*)N(*)*)C1N(*)C=NC1(*)C(O*)=O 0.000 description 1
- PJANRNHWOROTMQ-UHFFFAOYSA-N CN(C)C(C1CCC(CC1)C=O)C=1SC=CC1.CN(C)C(C1CCC(CC1)CC=O)C1=CC(=CC=C1)F Chemical compound CN(C)C(C1CCC(CC1)C=O)C=1SC=CC1.CN(C)C(C1CCC(CC1)CC=O)C1=CC(=CC=C1)F PJANRNHWOROTMQ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- CDEMHJCJMMOFMB-UHFFFAOYSA-M ClC1=CC=C([Mg]Br)C=C1 Chemical compound ClC1=CC=C([Mg]Br)C=C1 CDEMHJCJMMOFMB-UHFFFAOYSA-M 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 description 1
- WISDJZCDOIPUPG-UHFFFAOYSA-N acetaldehyde 2-[4-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]acetaldehyde 2-[4-[dimethylamino(thiophen-2-yl)methyl]cyclohexyl]acetaldehyde Chemical compound CN(C(CCC1=CC=CC=C1)C1CCC(CC1)CC=O)C.CN(C)C(C1CCC(CC1)CC=O)C=1SC=CC1.C(C)=O WISDJZCDOIPUPG-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000006193 alkinyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000003262 carboxylic acid ester group Chemical group [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- POCFBDFTJMJWLG-UHFFFAOYSA-N dihydrosinapic acid methyl ester Natural products COC(=O)CCC1=CC(OC)=C(O)C(OC)=C1 POCFBDFTJMJWLG-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000005469 ethylenyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- HTJPDOPKPWUNBX-UHFFFAOYSA-M magnesium;2h-thiophen-2-ide;bromide Chemical compound [Mg+2].[Br-].C=1C=[C-]SC=1 HTJPDOPKPWUNBX-UHFFFAOYSA-M 0.000 description 1
- OUTILEHLSPAZIN-UHFFFAOYSA-M magnesium;ethylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]CC1=CC=CC=C1 OUTILEHLSPAZIN-UHFFFAOYSA-M 0.000 description 1
- DTKMKZYEOXZPQZ-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=C[C-]=C1 DTKMKZYEOXZPQZ-UHFFFAOYSA-M 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- NSTZLDSLYUBZIK-UHFFFAOYSA-N methyl 2-(2-methylpropyl)-1-propyl-4,5-dihydroimidazole-4-carboxylate Chemical compound CCCN1CC(C(=O)OC)N=C1CC(C)C NSTZLDSLYUBZIK-UHFFFAOYSA-N 0.000 description 1
- CEPQFHINGYLWCQ-UHFFFAOYSA-N methyl 2-isocyano-3-phenylpropanoate Chemical compound COC(=O)C([N+]#[C-])CC1=CC=CC=C1 CEPQFHINGYLWCQ-UHFFFAOYSA-N 0.000 description 1
- LISXUQRUESFTRY-UHFFFAOYSA-N methyl 3,5-dibutyl-4-[2-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1C1C(CCCC1)C(N(C)C)C1=CC=C(C=C1)Cl)CCCC)CCCC LISXUQRUESFTRY-UHFFFAOYSA-N 0.000 description 1
- KVCCTRXBOPIEFP-UHFFFAOYSA-N methyl 3-benzyl-4-[4-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]-5-(methylsulfanylmethyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=C(F)C=CC=2)CCC1C1C(C(=O)OC)(CSC)N=CN1CC1=CC=CC=C1 KVCCTRXBOPIEFP-UHFFFAOYSA-N 0.000 description 1
- OLGWKMSUYJRHBU-UHFFFAOYSA-N methyl 3-benzyl-4-[[4-[dimethylamino-(4-fluorophenyl)methyl]cyclohexyl]methyl]-5-(3-methoxy-3-oxopropyl)-4h-imidazole-5-carboxylate Chemical compound C1CC(C(N(C)C)C=2C=CC(F)=CC=2)CCC1CC1C(CCC(=O)OC)(C(=O)OC)N=CN1CC1=CC=CC=C1 OLGWKMSUYJRHBU-UHFFFAOYSA-N 0.000 description 1
- UIYHYZSTJMJECZ-UHFFFAOYSA-N methyl 3-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1C1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 UIYHYZSTJMJECZ-UHFFFAOYSA-N 0.000 description 1
- JKKRXGFEQPJLSA-UHFFFAOYSA-N methyl 3-butyl-4-[[2-[dimethylamino-(3-fluorophenyl)methyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1C(CCCC1)C(C1=CC(=CC=C1)F)N(C)C)CCCC)CCSC JKKRXGFEQPJLSA-UHFFFAOYSA-N 0.000 description 1
- ZBXMJJGPSGFDFQ-UHFFFAOYSA-N methyl 3-butyl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-4h-imidazole-5-carboxylate Chemical compound CCCCN1C=NC(CC(C)C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 ZBXMJJGPSGFDFQ-UHFFFAOYSA-N 0.000 description 1
- CWOBLOUUHSQOTK-UHFFFAOYSA-N methyl 3-cyclohexyl-4-[[2-[1-(dimethylamino)-3-phenylpropyl]cyclohexyl]methyl]-5-(2-methylsulfanylethyl)-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1C(CCCC1)C(CCC1=CC=CC=C1)N(C)C)C1CCCCC1)CCSC CWOBLOUUHSQOTK-UHFFFAOYSA-N 0.000 description 1
- RFTDGMSDPLSJSQ-UHFFFAOYSA-N methyl 4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-5-(2-methylpropyl)-3-propyl-4h-imidazole-5-carboxylate Chemical compound CCCN1C=NC(CC(C)C)(C(=O)OC)C1CC1CCC(C(N(C)C)C=2C=CC(Cl)=CC=2)CC1 RFTDGMSDPLSJSQ-UHFFFAOYSA-N 0.000 description 1
- WUMLPDPFFWWRBZ-UHFFFAOYSA-N methyl 5-butan-2-yl-4-[[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound CCC(C)C1(C(=O)OC)N=CN(C2CCCCC2)C1CC(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 WUMLPDPFFWWRBZ-UHFFFAOYSA-N 0.000 description 1
- YIWSNSGYITWXGY-UHFFFAOYSA-N methyl 5-butyl-4-[4-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]-3-cyclohexyl-4h-imidazole-5-carboxylate Chemical compound CCCCC1(C(=O)OC)N=CN(C2CCCCC2)C1C(CC1)CCC1C(N(C)C)C1=CC=C(Cl)C=C1 YIWSNSGYITWXGY-UHFFFAOYSA-N 0.000 description 1
- LNYRPOJYSUEDJA-UHFFFAOYSA-N methyl 5-butyl-4-[[2-[(4-chlorophenyl)-(dimethylamino)methyl]cyclohexyl]methyl]-3-cyclohexyl-4H-imidazole-5-carboxylate Chemical compound COC(=O)C1(N=CN(C1CC1C(CCCC1)C(N(C)C)C1=CC=C(C=C1)Cl)C1CCCCC1)CCCC LNYRPOJYSUEDJA-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000006194 pentinyl group Chemical group 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000006238 prop-1-en-1-yl group Chemical group [H]\C(*)=C(/[H])C([H])([H])[H] 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 230000000697 serotonin reuptake Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005061430A DE102005061430A1 (de) | 2005-12-22 | 2005-12-22 | Substituierte Imidazolin-Derivate |
| DE102005061430.2 | 2005-12-22 | ||
| PCT/EP2006/012221 WO2007079927A1 (de) | 2005-12-22 | 2006-12-19 | Substituierte imidazolin-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2633918A1 true CA2633918A1 (en) | 2007-07-19 |
Family
ID=37946192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002633918A Abandoned CA2633918A1 (en) | 2005-12-22 | 2006-12-19 | Substituted imidazoline derivatives |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7728028B2 (enExample) |
| EP (1) | EP1963278B1 (enExample) |
| JP (1) | JP2009523124A (enExample) |
| CN (1) | CN101384557A (enExample) |
| AT (1) | ATE449075T1 (enExample) |
| AU (1) | AU2006334743B2 (enExample) |
| CA (1) | CA2633918A1 (enExample) |
| CY (1) | CY1110465T1 (enExample) |
| DE (2) | DE102005061430A1 (enExample) |
| DK (1) | DK1963278T3 (enExample) |
| ES (1) | ES2336833T3 (enExample) |
| IL (1) | IL192268A0 (enExample) |
| PL (1) | PL1963278T3 (enExample) |
| PT (1) | PT1963278E (enExample) |
| RU (1) | RU2427571C2 (enExample) |
| SI (1) | SI1963278T1 (enExample) |
| WO (1) | WO2007079927A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2257526T3 (pl) | 2008-03-27 | 2012-05-31 | Gruenenthal Gmbh | Pochodne spiro (5.5) undekanu |
| US8357705B2 (en) | 2008-03-27 | 2013-01-22 | Gruenenthal Gmbh | Substituted cyclohexyldiamines |
| ES2694103T3 (es) | 2008-03-27 | 2018-12-18 | Grünenthal GmbH | Derivados de 4-aminociclohexano sustituidos |
| CL2009000731A1 (es) | 2008-03-27 | 2009-05-15 | Gruenenthal Gmbh | Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea. |
| JP5599774B2 (ja) | 2008-03-27 | 2014-10-01 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ヒドロキシメチルシクロヘキシルアミン類 |
| HUE026184T2 (en) | 2008-03-27 | 2016-05-30 | Gruenenthal Gmbh | (Hetero-) aryl-cyclohexane derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9034798A (en) * | 1997-08-28 | 1999-03-16 | Eli Lilly And Company | Method for treating pain |
| US5952360A (en) * | 1997-08-28 | 1999-09-14 | Eli Lilly And Company | Method for treating neuropathic pain |
| DE10000312A1 (de) * | 2000-01-05 | 2001-07-12 | Gruenenthal Gmbh | Substituierte Aminomethyl-Phenyl-Cyclohexanderivate |
| US7183276B2 (en) * | 2002-02-28 | 2007-02-27 | Takeda Pharmaceutical Company Limited | Azole compounds |
| US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
| US7345078B2 (en) * | 2002-05-31 | 2008-03-18 | The Board Of Trustees Of Michigan State University | NF-κB inhibitors and uses thereof |
| DE102005061429A1 (de) * | 2005-12-22 | 2007-06-28 | Grünenthal GmbH | Substituierte Oxazol-Derivate |
-
2005
- 2005-12-22 DE DE102005061430A patent/DE102005061430A1/de not_active Withdrawn
-
2006
- 2006-12-19 AT AT06841028T patent/ATE449075T1/de active
- 2006-12-19 PT PT06841028T patent/PT1963278E/pt unknown
- 2006-12-19 JP JP2008546224A patent/JP2009523124A/ja not_active Ceased
- 2006-12-19 RU RU2008129377/04A patent/RU2427571C2/ru not_active IP Right Cessation
- 2006-12-19 DE DE502006005426T patent/DE502006005426D1/de active Active
- 2006-12-19 CN CNA2006800532577A patent/CN101384557A/zh active Pending
- 2006-12-19 SI SI200630546T patent/SI1963278T1/sl unknown
- 2006-12-19 ES ES06841028T patent/ES2336833T3/es active Active
- 2006-12-19 WO PCT/EP2006/012221 patent/WO2007079927A1/de not_active Ceased
- 2006-12-19 EP EP06841028A patent/EP1963278B1/de not_active Not-in-force
- 2006-12-19 DK DK06841028.1T patent/DK1963278T3/da active
- 2006-12-19 AU AU2006334743A patent/AU2006334743B2/en not_active Ceased
- 2006-12-19 CA CA002633918A patent/CA2633918A1/en not_active Abandoned
- 2006-12-19 PL PL06841028T patent/PL1963278T3/pl unknown
-
2008
- 2008-06-18 IL IL192268A patent/IL192268A0/en unknown
- 2008-06-20 US US12/143,566 patent/US7728028B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 CY CY20101100093T patent/CY1110465T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1963278E (pt) | 2009-12-16 |
| SI1963278T1 (sl) | 2010-03-31 |
| DE502006005426D1 (de) | 2009-12-31 |
| EP1963278B1 (de) | 2009-11-18 |
| US20090048323A1 (en) | 2009-02-19 |
| ATE449075T1 (de) | 2009-12-15 |
| AU2006334743A1 (en) | 2007-07-19 |
| RU2427571C2 (ru) | 2011-08-27 |
| CN101384557A (zh) | 2009-03-11 |
| US7728028B2 (en) | 2010-06-01 |
| WO2007079927A1 (de) | 2007-07-19 |
| CY1110465T1 (el) | 2015-04-29 |
| AU2006334743B2 (en) | 2011-07-07 |
| HK1122019A1 (zh) | 2009-05-08 |
| EP1963278A1 (de) | 2008-09-03 |
| IL192268A0 (en) | 2008-12-29 |
| DE102005061430A1 (de) | 2007-07-05 |
| DK1963278T3 (da) | 2010-03-29 |
| JP2009523124A (ja) | 2009-06-18 |
| PL1963278T3 (pl) | 2010-04-30 |
| RU2008129377A (ru) | 2010-03-27 |
| ES2336833T3 (es) | 2010-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2503660C2 (ru) | Замещенные производные 4-аминоциклогексана | |
| US8124788B2 (en) | Spirocyclic cyclohexane compounds with analgesic activity | |
| NZ568285A (en) | 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents | |
| RU2440344C2 (ru) | Применение 2-имидазолов для лечения расстройств цнс | |
| AU2006215567B2 (en) | 1H-imidazole derivatives as cannabinoid CB2 receptor modulators | |
| AU2008270445A1 (en) | 2 -imidazolines having a good affinity to the trace amine associated receptors (TAARs) | |
| BRPI0718059A2 (pt) | Aminometil-2-imidazóis com afinidade com os receptores amina-associado traço | |
| US7728028B2 (en) | Substituted imidazoline compounds | |
| US20100204233A1 (en) | Imidazole derivatives | |
| US7608619B2 (en) | Substituted oxazole compounds with analgesic activity | |
| CA2563017C (en) | Substituted cyclohexylacetic acid derivatives | |
| ES2411508T3 (es) | Derivados de oxadiazol sustituidos y su utilización como ligandos de los receptor opioides | |
| AU2004283903B2 (en) | 1H-imidazole derivatives as cannabinoid receptor modulators | |
| CA2562539C (en) | Substituted cyclohexylcarboxylic acid derivatives | |
| MX2008008067A (en) | Substituted imidazoline derivatives | |
| HK1122019B (en) | Substituted imidazoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20131219 |